Abstract: A display device includes: a first substrate including emission areas and a peripheral area surrounding the emission areas; a light emitting element layer on the first substrate and overlapping the emission areas; a plurality of light control patterns overlapping the emission areas and the peripheral area and on the light emitting element layer; and a transmission pattern between the plurality of light control patterns and having a refractive index of about 1.2 or more and less than about 1.5.

Abstract: The present application relates to a peptide having protective activity against cell damage caused by particulate matter, and to uses for the peptide.

Abstract: A display device is disclosed that includes a substrate including light emitting areas and a peripheral area surrounding the light emitting areas, a light emitting element layer disposed on the substrate and overlapping the light emitting areas, an encapsulation layer disposed on the light emitting element layer and a first pattern layer disposed on the encapsulation layer, and including first extension parts extending in a first direction and first connection parts connecting adjacent first extension parts among the first extension parts to each other.

Abstract: An embodiment of the present invention provides a pull-out system comprising: at least two slide rails each having a fixed rail, an intermediate rail slidably disposed on the fixed rail, and a moving rail slidably disposed on the intermediate rail; and a synchronization means for synchronizing movements of the respective slide rails with each other.

Abstract: An embodiment of the present invention provides a sliding device comprising: a first rail member which is open at one side surface thereof; a second rail member which slides on the first rail member and is open at one side surface thereof; and ball members which are disposed between the first rail member and the second rail member such that at least three ball members are provided as seen in a cross section, wherein the first rail member and the second rail member are arranged to be engaged with each other through the open side surfaces.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating cancer comprising an antiviral agent and an antidepressant as an active ingredient and to which a biguanide-based compound can be added, and more specifically, efavirenz, etravirine, rilpivirine, lopinavir, atazanavir, darunavir, and ritonavir as an antiviral agent, and fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, amitriptyline, clomipramine, nortriptyline, desipramine, amoxapine, maprotilline, trimipramine, protriptyline, and melithracene as an antidepressant, in complex, mixture, or combination administration, or efavirenz and fluoxetine with metformin, a biguanide compound, in complex, mixture, or combination administration, shows the significant synergistic anti-cancer activity than when each was administered alone, and so, finally the antiviral agent and antidepressant according to the present invention can be effectively used as an active ingredient in a composition for preventing or treating cancer.

Abstract: Provided is a rail device for a dishwasher, including a guide main body part; an upper support roller part coupled to one side of the guide main body part to be rotatable with respect to a central axis; a lower support roller part coupled to one side of the guide main body part to be rotatable with respect to a central axis; a guide rail part extendedly formed along the sliding direction with one side inserted into a space between the upper support roller part and the lower support roller part; and a rack roller part having one side inserted into the guide rail part and the other side coupled to one surface inside the main body of the dishwasher or coupled to a sliding basket.

Abstract: Provided herein are methods of generating optimized models of vascular grafts for subjects in certain embodiments. Methods of treating subjects in need of vascular grafts are also provided. Related systems and computer program products are additionally provided.

Abstract: Provided is an information output apparatus including one or more information output units, wherein each information output unit includes a coil arranged to be connected to a power source, such that a current flows in the coil; a base unit configured to accommodate the coil; and a driving indicator, which is arranged in the base unit to be apart from and close to the coil to be driven by a current flowing in the coil and is configured to move in a first direction toward the coil and a direction opposite thereto to rotate while being connected to the base unit and to move in a second direction crossing the first direction to be recognized by a user.

Abstract: A pharmaceutical composition for treating Gram negative bacteria-associated infections includes an antibacterial protein that includes at least one selected from the group consisting of a protein having the amino acid sequence as set forth in SEQ ID NO: 1, a protein having the amino acid sequence as set forth in SEQ ID NO: 2, a protein having the amino acid sequence as set forth in SEQ ID NO: 3, a protein having the amino acid sequence as set forth in SEQ ID NO: 4, a protein having the amino acid sequence as set forth in SEQ ID NO: 5, a protein having the amino acid sequence as set forth in SEQ ID NO: 6, a protein having the amino acid sequence as set forth in SEQ ID NO: 7, and a protein having the amino acid sequence as set forth in SEQ ID NO: 8. A method of preparing the antibacterial protein is also disclosed.

Abstract: A pharmaceutical composition for treating Gram negative bacteria-associated infections includes an antibacterial protein that includes at least one selected from the group of a protein having the amino acid sequence as set forth in SEQ ID NO: 1, a protein having the amino acid sequence as set forth in SEQ ID NO: 2, a protein having the amino acid sequence as set forth in SEQ ID NO: 3, a protein having the amino acid sequence as set forth in SEQ ID NO: 4, a protein having the amino acid sequence as set forth in SEQ ID NO: 5, a protein having the amino acid sequence as set forth in SEQ ID NO: 6, a protein having the amino acid sequence as set forth in SEQ ID NO: 7, and a protein having the amino acid sequence as set forth in SEQ ID NO: 8. A method of preparing the antibacterial protein is also disclosed.

Abstract: A pharmaceutical composition for treating Gram negative bacteria-associated infections includes an antibacterial protein that includes at least one selected from the group of a protein having the amino acid sequence as set forth in SEQ ID NO: 1, a protein having the amino acid sequence as set forth in SEQ ID NO: 2, a protein having the amino acid sequence as set forth in SEQ ID NO: 3, a protein having the amino acid sequence as set forth in SEQ ID NO: 4, a protein having the amino acid sequence as set forth in SEQ ID NO: 5, a protein having the amino acid sequence as set forth in SEQ ID NO: 6, a protein having the amino acid sequence as set forth in SEQ ID NO: 7, and a protein having the amino acid sequence as set forth in SEQ ID NO: 8. A method of preparing the antibacterial protein is also disclosed.

Abstract: The present invention relates to a pharmaceutical composition comprising trimethobenzamide or a pharmaceutically acceptable salt thereof as an active ingredient for preventing or treating neuropathy. Trimethobenzamide, when administered in combination with tramadol, exhibits the effect of significantly reducing pain in a neuropathy animal model and as such, can be advantageously used for treatment of neuropathy.

Abstract: Provided is a method for manufacturing a stent, including: coating a coating material on a stent; and drying the stent at a temperature in the range of from 40° C. to 150° C., and the coating and the drying are simultaneously performed.

Abstract: Disclosed are a pharmaceutical composition for preventing or treating a skin disease containing a purple corn extract, and more particularly, to a pharmaceutical composition for preventing or treating a skin disease containing a purple corn extract that has a potent effect of preventing or treating at least one skin disease selected from the group consisting of atopy, psoriasis, eczema, keratosis, prurigo and warts, using the purple corn extract.

Abstract: Provided is a method for manufacturing a stent, including: coating a coating material on a stent; and drying the stent at a temperature in the range of from 40° C. to 150° C., and the coating and the drying are simultaneously performed.

Abstract: Provided is an information output apparatus including one or more information output units, wherein each information output unit includes a coil arranged to be connected to a power source, such that a current flows in the coil; a base unit configured to accommodate the coil; and a driving indicator, which is arranged in the base unit to be apart from and close to the coil to be driven by a current flowing in the coil and is configured to move in a first direction toward the coil and a direction opposite thereto to rotate while being connected to the base unit and to move in a second direction crossing the first direction to be recognized by a user.

Abstract: Disclosed are a pharmaceutical composition for preventing or treating a skin disease containing a purple corn extract, and more particularly, to a pharmaceutical composition for preventing or treating a skin disease containing a purple corn extract that has a potent effect of preventing or treating at least one skin disease selected from the group consisting of atopy, psoriasis, eczema, keratosis, prurigo and warts, using the purple corn extract.